|
1
|
Choi SH, Aid S, Choi U and Bosetti F:
Cyclooxygenases-1 and -2 differentially modulate leukocyte
recruitment into the inflamed brain. Pharmacogenomics J.
10:448–457. 2010. View Article : Google Scholar
|
|
2
|
McGeer PL, Itagaki S, Tago H and McGeer
EG: Reactive microglia in patients with senile dementia of the
Alzheimer type are positive for the histocompatibility glycoprotein
HLA-DR. Neurosci Lett. 79:195–200. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Haga S, Akai K and Ishii T: Demonstration
of microglial cells in and around senile (neuritic) plaques in the
Alzheimer brain. An immunohistochemical study using a novel
monoclonal antibody. Acta Neuropathol. 77:569–575. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wisniewski HM, Wegiel J, Wang KC and Lach
B: Ultrastructural studies of the cells forming amyloid in the
cortical vessel wall in Alzheimer's disease. Acta Neuropathol.
84:117–127. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McGeer PL, Schulzer M and McGeer EG:
Arthritis and anti-inflammatory agents as possible protective
factors for Alzheimer's disease: A review of 17 epidemiologic
studies. Neurology. 47:425–432. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
in t'Veld BA, Ruitenberg A, Hofman A,
Launer LJ, van Duijn CM, Stijnen T, Breteler MM and Stricker BH:
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's
disease. N Engl J Med. 345:1515–1521. 2001. View Article : Google Scholar
|
|
7
|
McGeer PL and McGeer EG: NSAIDs and
Alzheimer disease: Epidemiological, animal model and clinical
studies. Neurobiol Aging. 28:639–647. 2007. View Article : Google Scholar
|
|
8
|
Lim GP, Yang F, Chu T, Chen P, Beech W,
Teter B, Tran T, Ubeda O, Ashe KH, Frautschy SA and Cole GM:
Ibuprofen suppresses plaque pathology and inflammation in a mouse
model for Alzheimer's disease. J Neurosci. 20:5709–5714.
2000.PubMed/NCBI
|
|
9
|
Lim GP, Yang F, Chu T, Gahtan E, Ubeda O,
Beech W, Overmier JB, Hsiao-Ashec K, Frautschy SA and Cole GM:
Ibuprofen effects on Alzheimer pathology and open field activity in
APPsw transgenic mice. Neurobiol Aging. 22:983–991. 2001.
View Article : Google Scholar
|
|
10
|
McKee AC, Carreras I, Hossain L, Ryu H,
Klein WL, Oddo S, LaFerla FM, Jenkins BG, Kowall NW and Dedeoglu A:
Ibuprofen reduces Abeta, hyperphosphorylated tau and memory
deficits in Alzheimer mice. Brain Res. 1207:225–236. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Choi SH, Aid S, Caracciolo L, Minami SS,
Niikura T, Matsuoka Y, Turner RS, Mattson MP and Bosetti F:
Cyclooxygenase-1 inhibition reduces amyloid pathology and improves
memory deficits in a mouse model of Alzheimer's disease. J
Neurochem. 124:59–68. 2013. View Article : Google Scholar :
|
|
12
|
Williams CS and DuBois RN: Prostaglandin
endoperoxide synthase: Why two isoforms? Am J Physiol.
270:G393–G400. 1996.PubMed/NCBI
|
|
13
|
Candelario-Jalil E: A role for
cyclooxygenase-1 in beta-amyloid-induced neuroinflammation. Aging
(Albany NY). 1:350–353. 2009.
|
|
14
|
Kelley KA, Ho L, Winger D, Freire-Moar J,
Borelli CB, Aisen PS and Pasinetti GM: Potentiation of
excitotoxicity in transgenic mice overexpressing neuronal
cyclooxygenase-2. Am J Pathol. 155:995–1004. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hoozemans JJ, Rozemuller AJ, Janssen I, De
Groot CJ, Veerhuis R and Eikelenboom P: Cyclooxygenase expression
in microglia and neurons in Alzheimer's disease and control brain.
Acta Neuropathol. 101:2–8. 2001.PubMed/NCBI
|
|
16
|
Li XB, Zheng H, Zhang ZR, Li M, Huang ZY,
Schluesener HJ, Li YY and Xu SQ: Glia activation induced by
peripheral administration of aluminum oxide nanoparticles in rat
brains. Nanomedicine. 5:473–479. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Garcia-Bueno B, Serrats J and Sawchenko
PE: Cerebrovascular cyclooxygenase-1 expression, regulation and
role in hypothalamic-pituitary-adrenal axis activation by
inflammatory stimuli. J Neurosci. 29:12970–12981. 2009. View Article : Google Scholar
|
|
18
|
Matousek SB, Hein AM, Shaftel SS,
Olschowka JA, Kyrkanides S and O'Banion MK: Cyclooxygenase-1
mediates prostaglandin E(2) elevation and contextual memory
impairment in a model of sustained hippocampal interleukin-1beta
expression. J Neurochem. 114:247–258. 2010.PubMed/NCBI
|
|
19
|
Choi SH and Bosetti F: Cyclooxygenase-1
null mice show reduced neuroinflammation in response to
beta-amyloid. Aging (Albany NY). 1:234–244. 2009.
|
|
20
|
Choi SH, Langenbach R and Bosetti F:
Genetic deletion or pharmacological inhibition of cyclooxygenase-1
attenuate lipopolysaccharide-induced inflammatory response and
brain injury. FASEB J. 22:1491–1501. 2008. View Article : Google Scholar :
|
|
21
|
Candelario-Jalil E, de Oliveira AC, Gräf
S, Bhatia HS, Hüll M, Muñoz E and Fiebich BL: Resveratrol potently
reduces prostaglandin E2 production and free radical formation in
lipopolysaccharide-activated primary rat microglia. J
Neuroinflammation. 4:252007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Candelario-Jalil E, Taheri S, Yang Y, Sood
R, Grossetete M, Estrada EY, Fiebich BL and Rosenberg GA:
Cyclooxygenase inhibition limits blood-brain barrier disruption
following intracerebral injection of tumor necrosis factor-alpha in
the rat. J Pharmacol Exp Ther. 323:488–498. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ahmed T and Gilani AH: A comparative study
of curcuminoids to measure their effect on inflammatory and
apoptotic gene expression in an Aβ plus ibotenic acid-infused rat
model of Alzheimer's disease. Brain Res. 1400:1–18. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Masferrer JL, Zweifel BS, Seibert K and
Needleman P: Selective regulation of cellular cyclooxygenase by
dexamethasone and endotoxin in mice. J Clin Invest. 86:1375–1379.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Choi SH, Aid S and Bosetti F: The distinct
roles of cyclooxygenase-1 and -2 in neuroinflammation: Implications
for translational research. Trends Pharmacol Sci. 30:174–181. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hoozemans JJ, Rozemuller JM, van Haastert
ES, Veerhuis R and Eikelenboom P: Cyclooxygenase-1 and -2 in the
different stages of Alzheimer's disease pathology. Curr Pharm Des.
14:1419–1427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Niwa K, Araki E, Morham SG, Ross ME and
Iadecola C: Cyclooxygenase-2 contributes to functional hyperemia in
whisker-barrel cortex. J Neurosci. 20:763–770. 2000.PubMed/NCBI
|
|
28
|
Yang H and Chen C: Cyclooxygenase-2 in
synaptic signaling. Curr Pharm Des. 14:1443–1451. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pasinetti GM and Aisen PS:
Cyclooxygenase-2 expression is increased in frontal cortex of
Alzheimer's disease brain. Neuroscience. 87:319–324. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fujimi K, Noda K, Sasaki K, Wakisaka Y,
Tanizaki Y, Iida M, Kiyohara Y, Kanba S and Iwaki T: Altered
expression of COX-2 in subdivisions of the hippocampus during aging
and in Alzheimer's disease: The Hisayama study. Dement Geriatr Cogn
Disord. 23:423–431. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yermakova AV and O'Banion MK:
Downregulation of neuronal cyclooxygenase-2 expression in end stage
Alzheimer's disease. Neurobiol Aging. 22:823–836. 2001. View Article : Google Scholar
|
|
32
|
Tocco G, Freire-Moar J, Schreiber SS,
Sakhi SH, Aisen PS and Pasinetti GM: Maturational regulation and
regional induction of cyclooxygenase-2 in rat brain: Implications
for Alzheimer's disease. Exp Neurol. 144:339–349. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Miettinen S, Fusco FR, Yrjünheikki J,
Keinänen R, Hirvonen T, Roivainen R, Närhi M, Hökfelt T and
Koistinaho J: Spreading depression and focal brain ischemia induce
cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic
acid-receptors and phospholipase A2. Proc Natl Acad Sci USA.
94:6500–6505. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Greenberg ER and Baron JA: Aspirin and
other nonsteroid anti-inflammatory drugs as cancer-preventive
agents. IARC Sci Publ. 91–98. 1996.PubMed/NCBI
|
|
35
|
Abd-Elhady RM, Elsheikh AM and Khalifa AE:
Anti-amnestic properties of Ginkgo biloba extract on impaired
memory function induced by aluminum in rats. Int J Dev Neurosci.
31:598–607. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Belaid-Nouira Y, Bakhta H, Bouaziz M,
Flehi-Slim I, Haouas Z and Ben Cheikh H: Study of lipid profile and
parieto-temporal lipid peroxidation in AlCl3 mediated
neurotoxicity. Modulatory effect of fenugreek seeds. Lipids Health
Dis. 11:162012. View Article : Google Scholar
|
|
37
|
Meyer-Baron M, Schäper M, Knapp G and van
Thriel C: Occupational aluminum exposure: Evidence in support of
its neurobehavioral impact. Neurotoxicology. 28:1068–1078. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hashmi AN, Yaqinuddin A and Ahmed T:
Pharmacological effects of Ibuprofen on learning and memory,
muscarinic receptors genes expression and APP isoforms levels in
Pre-frontal cortex of AlCl3-induced toxicity mouse model. Int J
Neurosci. 125:277–287. 2015. View Article : Google Scholar
|
|
39
|
Bondy SC: The neurotoxicity of
environmental aluminum is still an issue. Neurotoxicology.
31:575–581. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Andrasi E, Páli N, Molnár Z and Kösel S:
Brain aluminum, magnesium and phosphorus contents of control and
Alzheimer-diseased patients. J Alzheimers Dis. 7:273–284.
2005.PubMed/NCBI
|
|
41
|
National Research Council: Guide for the
care and use of laboratory animals. Washington, D.C: National
Academy Press; 1996
|
|
42
|
Thirunavukkarasu SV, Venkataraman S, Raja
S and Upadhyay L: Neuroprotective effect of Manasamitra vatakam
against aluminium induced cognitive impairment and oxidative damage
in the cortex and hippocampus of rat brain. Drug Chem Toxicol.
35:104–115. 2012. View Article : Google Scholar
|
|
43
|
Ahmed T and Gilani AH: Inhibitory effect
of curcuminoids on acetylcholinesterase activity and attenuation of
scopolamine-induced amnesia may explain medicinal use of turmeric
in Alzheimer's disease. Pharmacol Biochem Behav. 91:554–559. 2009.
View Article : Google Scholar
|
|
44
|
Meeker HC, Chadman KK, Heaney AT and Carp
RI: Assessment of social interaction and anxiety-like behavior in
senescence-accelerated-prone and -resistant mice. Physiol Behav.
118:97–102. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Deacon R: Assessing burrowing, nest
construction and hoarding in mice. J Vis Exp. e26072012.
|
|
46
|
Ahmed T, Enam SA and Gilani AH:
Curcuminoids enhance memory in an amyloid-infused rat model of
Alzheimer's disease. Neuroscience. 169:1296–1306. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Habila N, Agbaji AS, Ladan Z, Bello IA,
Haruna E, Dakare MA and Atolagbe TO: Evaluation of in vitro
activity of essential oils against trypanosoma brucei brucei and
trypanosoma evansi. J Parasitol Res. 2010:2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kotilinek LA, Westerman MA, Wang Q,
Panizzon K, Lim GP, Simonyi A, Lesne S, Falinska A, Younkin LH,
Younkin SG, et al: Cyclooxygenase-2 inhibition improves
amyloid-beta-mediated suppression of memory and synaptic
plasticity. Brain. 131:651–664. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bickart KC, Hollenbeck MC, Barrett LF and
Dickerson BC: Intrinsic amygdala-cortical functional connectivity
predicts social network size in humans. J Neurosci. 32:14729–14741.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Guo JY, Li CY, Ruan YP, Sun M, Qi XL, Zhao
BS and Luo F: Chronic treatment with celecoxib reverses chronic
unpredictable stress-induced depressive-like behavior via reducing
cyclo-oxygenase-2 expression in rat brain. Eur J Pharmacol.
612:54–60. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Min Z, Wang S, Wu J and Zhang S:
Impairment of nesting behavior in APPswe/PS1dE9 mice. Life Sci J.
10:1942–1945. 2013.
|
|
52
|
Deacon RM, Croucher A and Rawlins JN:
Hippocampal cytotoxic lesion effects on species-typical behaviours
in mice. Behav Brain Res. 132:203–213. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Holson RR and Walker C: Mesial prefrontal
cortical lesions and timidity in rats II Reactivity to novel
stimuli. Physiol Behav. 37:231–238. 1986. View Article : Google Scholar
|
|
54
|
Rogers J, Kirby LC, Hempelman SR, Berry
DL, McGeer PL, Kaszniak AW, Zalinski J, Cofield M, Mansukhani L and
Willson P: Clinical trial of indomethacin in Alzheimer's disease.
Neurology. 43:1609–1611. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Reines SA, Block GA, Morris JC, Liu G,
Nessly ML, Lines CR, Norman BA and Baranak CC; Rofecoxib Protocol
091 Study Group: Rofecoxib: No effect on Alzheimer's disease in a
1-year, randomized, blinded, controlled study. Neurology. 62:66–71.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Smith MA, Rottkamp CA, Nunomura A, Raina
AK and Perry G: Oxidative stress in Alzheimer's disease. Biochim
Biophys Acta. 1502:139–144. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chazot G and Broussolle E: Alterations in
trace elements during brain aging and in Alzheimer's dementia. Prog
Clin Biol Res. 380:269–281. 1993.PubMed/NCBI
|
